Differences in the prognosis of gastric cancer patients of different sexes and races and the molecular mechanisms involved
Differences in the prognosis of gastric cancer patients of different sexes and races and the molecular mechanisms involved
复制标题
DOI:
10.3892/ijo.2019.4885
复制
发表时间:
2019-11-01
影响因子:
5.2
通讯作者:
Zhang, Changhua
中科院分区:
文献类型:
--
作者:
Li, Huafu;Wang, Chunming;Zhang, Changhua
To evaluate the prognostic and molecular mechanisms of sex and racial differences in gastric cancer, data from two large centers were used to retrospectively analyze the survival of gastric cancer patients with regard to sex and racial differences. In examining the molecular mechanism of sex in gastric cancer patients of different races, data from The Cancer Genome Atlas database were used to analyze differentially expressed genes (DEGs), and Gene Ontology (GO) enrichment and DNA methylation analyses were performed. Among White gastric cancer patients, it was found that the survival prognosis for females was better than that for males; conversely, among Chinese patients, males had a better prognosis. For African Americans, sex may have an impact on gastric cancer, but this relationship was unclear. The core DEGs between the different sexes included glycogenin 2 pseudogene 1, ribosomal protein S4 Y-linked 1, taxilin-gamma and eukaryotic translation initiation factor 1A X-linked among White patients, and GO enrichment analysis revealed that these genes act mainly through RNA binding and transcription pathways. Among Black patients, core DEGs included DnaJ heat shock protein family (Hsp40) member C5, histone deacetylase 10, neogenin 1 and SMG5 nonsense mediated mRNA decay factor, which are mainly related to pathways of cellular structural changes based on GO enrichment analysis. For Asian patients, core DEGs included zinc finger protein Y-linked, thymosin beta 4 Y-linked, zinc finger protein 787 and ubiquitously transcribed tetratricopeptide repeat containing, Y-linked, participating in cell surface receptor-associated signal transduction and G-protein coupled receptor protein signaling pathways, according to GO. The expression of different core genes and differences in path ways are likely to be the main causes affecting the variation observed among gastric cancer patients of different races and sexes.